In this case report, treatment of malignant melanoma with BRAF/MEK inhibitors was associated with radiological disease exacerbation of pre-existing multiple sclerosis (MS).<h4>Case presentation</h4>A 47-year-old patient with pre-existing MS was diagnosed with malignant melanoma in June 2020. Here, MAP2K7 is linked to myeloid sarcoma.